KRAS G12C inhibitor 39
KRAS G12C inhibitor 39 is a potent inhibitor of KRAS G12C. KRas is a highly attractable target of the pharmaceutical industry for cancer research. KRAS G12C inhibitor 39 has the potential for the research of KRAS G12C-mediated cancer (extracted from patent WO2019099524A1, compound 494).
For research use only. We do not sell to patients.
- CAS No.: 2326522-16-9
- Formula: C37H43N9O2
- Molecular Weight:645.80
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
Chemical Information
-
CAS No. 2326522-16-9
-
Molecular Weight 645.80
-
Formula C37H43N9O2
-
SMILES
N#CC[C@@H]1N(C(/C=C/C2=CN(C)N=C2)=O)CCN(C3=C4C(CN(C5=C6C(C)=CC=CC6=CC=C5)CC4)=NC(OC[C@H]7N(C)CCC7)=N3)C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
KRAS G12C inhibitor 39 Related Classifications
HY-143592 Related Classifications
Powered by Bioz